Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Krtap9-5 Inhibitors

Krtap9-5, a keratin-associated protein in mice, plays a pivotal role in cellular processes associated with identical protein binding activity. This suggests its involvement in molecular interactions crucial for maintaining cellular structure and function. The gene's orthology to human genes, such as KRTAP9-1, underscores its evolutionary conservation and potential functional significance across species. Krtap9-5 is predicted to be located in the cytosol, indicating its participation in intracellular events. While the precise function of Krtap9-5 remains to be fully elucidated, its involvement in identical protein binding points towards its contribution to molecular networks essential for various cellular functions.

The inhibition of Krtap9-5 involves a strategic approach targeting specific cellular pathways associated with its activity. Inhibitors such as mTOR inhibitor Rapamycin disrupt cellular processes downstream of mTOR, potentially impacting Krtap9-5 function. HDAC inhibitor Trichostatin A influences histone modifications, indirectly regulating Krtap9-5 and modulating cellular processes. Various inhibitors targeting TGF-β receptor, PI3K, JNK, p38 MAPK, EGFR, MEK, Wnt/β-catenin, and Rac1 pathways provide a comprehensive view of the intricate signaling networks connected to Krtap9-5. These inhibitors act at different points in these pathways, suggesting a nuanced regulation of Krtap9-5 function. Overall, the inhibition of Krtap9-5 reflects a complex interplay of diverse signaling cascades, contributing to our understanding of the molecular mechanisms governing this keratin-associated protein's role in cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor disrupting cellular processes, potentially impacting Krtap9-5 function.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

HDAC inhibitor affecting histone modifications, providing indirect regulation of Krtap9-5.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

TGF-β receptor inhibitor influencing cellular pathways associated with Krtap9-5.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor disrupting PI3K/AKT pathway, potentially modulating Krtap9-5 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor impacting JNK pathway, influencing cellular processes related to Krtap9-5.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor affecting p38 MAPK pathway, potentially altering Krtap9-5 function.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$85.00
$132.00
$287.00
$495.00
$3752.00
42
(0)

EGFR inhibitor potentially influencing downstream signaling pathways connected to Krtap9-5.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK inhibitor disrupting the MAPK pathway, potentially impacting Krtap9-5 activity.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$37.00
$77.00
$184.00
$510.00
$1224.00
$5814.00
8
(1)

Inhibits Wnt/β-catenin signaling, potentially affecting pathways connected to Krtap9-5.

GW788388

452342-67-5sc-363544
sc-363544A
5 mg
25 mg
$95.00
$384.00
(0)

TGF-β receptor kinase inhibitor, potentially influencing cellular processes associated with Krtap9-5.